U.S.-Israeli Talks Over Pharmaceutical Intellectual Property Regime Break Down
Talks between U.S. and Israeli officials over pharmaceutical intellectual property rights have collapsed amid increasing tension between multinational brand-name drug makers and Israel's burgeoning generics industry....To view the full article, register now.
Already a subscriber? Click here to view full article